Healthcare & Pharmaceuticals
September 19 2024 – Novartis not becoming a member of the ‘frenzy’ of weight reduction medicine, CEO says
September 19 2024 - Novartis not becoming a member of the ‘frenzy’ of weight reduction medicine, CEO says | Cafepharma You might be right hereDwelling » September 19 2024 -…
Your Trusted Source for Accurate and Timely Updates!
Lasted Healthcare & Pharmaceuticals
The hunt for game-changers towards the deadliest type of mind most cancers
Take heed to the article 7 min This audio is auto-generated. Please tell us when you've got suggestions. When docs…
Biopharma prepares to pivot from China as Biosecure Act advances
Take heed to the article 8 min This audio is auto-generated. Please tell us you probably have suggestions. A few…
Agility in motion: 5 methods to fast-track your medical trial
In terms of medical analysis, velocity and effectivity are important parts that may considerably impression the success of a medical…
September 13 2024 – Neurocrine's bid to save lots of schizophrenia prospect fails
September 13 2024 - Neurocrine's bid to save lots of schizophrenia prospect fails | Cafepharma You might be right hereResidence…
Who’s successful in biotech’s tight market?
Hearken to the article 5 min This audio is auto-generated. Please tell us in case you have suggestions. Biotech buyers…
September 12 2024 – Moderna targets $1.1B in R&D spending cuts, drops 5 applications amid profitability pressures
September 12 2024 - Moderna targets $1.1B in R&D spending cuts, drops 5 applications amid profitability pressures | Cafepharma You…
How Lilly’s sustainability objectives come head to head with large development
Take heed to the article 7 min This audio is auto-generated. Please tell us in case you have suggestions. In…
September 11 2024 – Roche ramps up R&D with $1.4B Swiss facility
September 11 2024 - Roche ramps up R&D with $1.4B Swiss facility | Cafepharma You're right hereDwelling » September 11…